Optimizing thiopurine therapy in children with acute lymphoblastic leukemia: A promising “MINT” sequencing strategy and therapeutic “DNA-TG” monitoring
Thiopurines, including thioguanine (TG), 6-mercaptopurine (6-MP), and azathioprine (AZA), are extensively used in clinical practice in children with acute lymphoblastic leukemia (ALL) and inflammatory bowel diseases. However, the common adverse effects caused by myelosuppression and hepatotoxicity l...
Main Authors: | Hong-Li Guo, Yue-Tao Zhao, Wei-Jun Wang, Na Dong, Ya-Hui Hu, Yuan-Yuan Zhang, Feng Chen, Li Zhou, Tao Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.941182/full |
Similar Items
-
Severe Myelotoxicity Associated with Thiopurine S-Methyltransferase*3A/*3C Polymorphisms in a Patient with Pediatric Leukemia and the Effect of Steroid Therapy
by: Burcu Fatma Belen, et al.
Published: (2014-12-01) -
Importance of genotyping of Thiopurine S-methyltransferase in children with acute lymphoblastic leukaemia during maintenance therapy
by: Dokmanović Lidija, et al.
Published: (2008-01-01) -
Thiopurine 6TG treatment increases tumor immunogenicity and response to immune checkpoint blockade
by: Loulieta Nazerai, et al.
Published: (2023-12-01) -
A direct sequencing assay for pharmacogenetic testing of thiopurine-intolerant NUDT15 alleles in an Asian population
by: Kok-Siong Poon, et al.
Published: (2022-04-01) -
TPMT and NUDT15 testing for thiopurine therapy: A major tertiary hospital experience and lessons learned
by: Liuh Ling Goh, et al.
Published: (2022-09-01)